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Abstract
Background: Two decades after the introduction of oil-based vaccines in the control of bacterial and viral diseases in 
farmed salmonids, the mechanisms of induced side effects manifested as intra-abdominal granulomas remain 
unresolved. Side effects have been associated with generation of auto-antibodies and autoimmunity but the 
underlying profile of inflammatory and immune response has not been characterized. This study was undertaken with 
the aim to elucidate the inflammatory and immune mechanisms of granuloma formation at gene expression level 
associated with high and low side effect (granuloma) indices.
Groups of Atlantic salmon parr were injected intraperitoneally with oil-adjuvanted vaccines containing either high or 
low concentrations of Aeromonas salmonicida or Moritella viscosa antigens in order to induce polarized (severe and 
mild) granulomatous reactions. The established granulomatous reactions were confirmed by gross and histological 
methods at 3 months post vaccination when responses were known to have matured. The corresponding gene 
expression patterns in the head kidneys were profiled using salmonid cDNA microarrays followed by validation by real-
time quantitative PCR (qPCR). qPCR was also used to examine the expression of additional genes known to be 
important in the adaptive immune response.
Results: Granulomatous lesions were observed in all vaccinated fish. The presence of severe granulomas was 
associated with a profile of up-regulation of innate immunity-related genes such as complement factors C1q and C6, 
mannose binding protein, lysozyme C, C-type lectin receptor, CD209, Cathepsin D, CD63, LECT-2, CC chemokine and 
metallothionein. In addition, TGF-β (p = 0.001), IL-17A (p = 0.007) and its receptor (IL-17AR) (p = 0.009) representing 
TH17 were significantly up-regulated in the group with severe granulomas as were arginase and IgM. None of the 
genes directly reflective of TH1 T cell lineage (IFN-γ, CD4) or TH2 (GATA-3) responses were differentially expressed.
Conclusions: Granulomatous reactions following vaccination with oil-based vaccines in Atlantic salmon have the 
profile of strong expression of genes related to innate immune responses. The expression of TGF-β, IL-17A and its 
receptor suggests an involvement of TH17 T cell lineage and is in conformity with strong infiltration of neutrophils and 
macrophages into inflamed areas. Arginase upregulation shows that macrophages in these reactions are alternatively 
activated, indicating also a TH2-profile. To what extent the expression of IL-17A and its receptor reflects an autoimmune 
vaccine-based reaction remains elusive but would be in conformity with previous observations of autoimmune 
reactions in salmon when vaccinated with oil-based vaccines.
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Background
In previous studies of concomitant histomorphological
changes and antigen retention in Atlantic salmon (Salmo
salar L.), we showed that intraperitoneal injection with
oil-adjuvanted vaccines induces injection-site granulo-
mas [1,2]. The mechanisms underlying the reactions are
not well understood. In higher vertebrates, two polar
forms of granulomas have traditionally been recognized
[3,4]. The first type consists of organized nodular lesions
comprising of epithelioid and multinucleate giant cells
towards the center of the lesions, surrounded by fibrous
tissue. Aggregates of lymphocytes are often present in the
periphery. This type of granulomas is associated with a
TH1 immune response and is dominated by interleukin
12 (IL-12), interferon-γ (IFN-γ), IL-2 and tumor necrosis
factor alpha (TNF-α) resulting in macrophage activation
and a strong cell-mediated immunity [5]. The second
type is characterized by a lack of organization and is a
TH2 type where IL-4, IL-5 and IL-13 dominate with acti-
vation of B cells, eosinophils, mast cells and a strong anti-
body production [6].
Recently, a third type of CD4 effector T cell lineage,
TH17, has been discovered following the realization that
mice deficient in IFN-γ or its receptor were not resistant
to experimental autoimmune encephalomyelitis, an auto-
immune disease previously associated with a TH1
response [7-11]. The TH17 effector cells are distinct from
TH1 or TH2 types and have a cytokine profile predomi-
nated by IL-17A, IL-17F, IL-6, IL-21 and IL-22 (reviewed
in ref. [12]). These T cells appear to function in the clear-
ance of pathogens that have not been adequately handled
by TH1 or TH2 cells but have also been implicated in sev-
eral autoimmune diseases [13].
In mammals, the differentiation of naïve CD4 T helper
cells into TH17 cells is induced by TGF-β in combination
with other cytokines such as IL-6, IL-21 and IL-23
[14,15]. IL-21 also plays an auto-amplification role for
TH17 cells while IL-23 is essential for stabilization [16,17].
IL-17 (IL-17A) is the hallmark of TH17 effector cells
whose functions though not fully understood, includes
the amplification of the immune response by the induc-
tion of other cytokines such as IL-6, TNFα, regulated on
activation normal T cell expressed and secreted
(RANTES) and monocyte chemoattractant protein-1
(MCP-1) [18,19]. Its capacity to cooperate with cytokines
of the innate immunity to promote inflammation sug-
gests that it is a bridge between innate and adaptive
responses [20]. IL-17 binds to its receptor (IL-17AR) on
target cells resulting in signaling via Act1 or CIKS,
TNFR-associated factor 6 (TRAF6) and NF-κB and plays
a role in inducing the recruitment of neutrophils and
macrophages [21-23].
In line with the T H1/TH2 paradigm, the type of mac-
rophage activation has been shown to parallel these
responses [24]. In mice, activated macrophages metabo-
lize arginine by two alternative pathways involving the
enzymes inducible nitric oxide synthase (iNOS) or argi-
nase [24]. Synthesis of reactive oxygen species (ROS) and
NO from L-arginine by iNOS in the so-called classical
pathway is associated with the TH1 response [25,26]. NO
is a crucial host-protective, antimicrobial effector mole-
cule as well as a potential host destructive mediator in
diverse settings of immunopathology [27-29]. On the
other hand, metabolism of arginine by arginase in the
alternative pathway, converting L-arginine into ornithine
and urea [24] is associated with the TH2 response. Mac-
rophages in this state of activation play an important role
against extracellular pathogens by showing increased
phagocytic activity and enhanced gene expression of
MHC class II. In addition, alternatively activated mac-
rophages promote proliferation and antibody class
switching and function in allergic reactions and wound
healing processes [30]. Both iNOS and arginase compete
for the common substrate L-arginine and the balance
between the two enzymes is competitively regulated by
TH1 and TH2 T helper cells via their secreted cytokines.
In Atlantic salmon, the presentation of granulomas fol-
lowing vaccination with oil-based vaccines is mainly in
the form of diffuse granulomatous infiltration of inflam-
m a t o r y  c e l l s  a l t h o u g h  i n  s o m e  c a s e s ,  m o r e  o r g a n i z e d
lesions with lymphocyte infiltrations have been observed.
There are, however, very few studies that address inflam-
matory or immunological reactions at genetic level. It is
not certain whether TH1/TH2/TH17 responses exist in
salmonids as in mammalian although many cytokines
known to drive these responses including IFN-γ have
been cloned, sequenced and characterized [31,32]. Inter-
estingly, the different pathways of arginine metabolism in
macrophages have been demonstrated [30,33-35] and
more recently, vaccine-associated autoimmunity has also
been implicated in Atlantic salmon [36].
Oil-adjuvanted vaccines act through several mecha-
nisms such as the "depot effect" where antigens are
retained at the injection site and released over extended
periods of time; the enhancement of antigen presentation
as well as antigen distribution or targeted immune activa-
tion [37]. In fish, antigens are retained in granulomas at
the injection site [2]. Their distribution to head kidney
and spleen following injection has been demonstrated
[38]. The head kidney acts as a 'draining lymph node' for
the peritoneal cavity in salmonids [39] and the retention
of antigens for months in the head kidney [38,40] demon-
strates that this organ plays a role in the immune
responses.Mutoloki et al. BMC Genomics 2010, 11:336
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In previous studies, we characterized the development
of granulomatous reactions following vaccination with oil
adjuvanted vaccines both grossly and histopathologically
[2,41,42]. In these studies, we demonstrated that different
antigens have different capacities to induce inflamma-
tion; and that the antigen-adjuvant combinations are
responsible for most of the injection-site pathology. We
also observed that the severity of inflammatory reactions
increased with antigen concentration in the vaccines [41].
I n  t h e  p r e s e n t  s t u d y ,  w e  h a v e  t a k e n  a d v a n t a g e  o f  t h i s
knowledge to develop skewed models of granulomatous
reactions for profiling genes involved in inflammatory
and immunological changes. The objective was to iden-
t i f y  g e n e  e x p r e s s i o n  p r o f i l e s  a s s o c i a t e d  w i t h  m i l d  a n d
severe granulomatous reactions by comparing the pat-
terns in fish injected with standard vaccines inducing
mild reactions on one side and those with severe reac-
tions (injected with vaccines containing 6× the antigen
concentration) on the other. Gross and histopathological
examinations of the pyloric caeca (injection-site), as well
as the gene expression profiles of both head kidney tis-
sues and injection site of the same individuals were exam-
ined side by side at 3 months post vaccination (when local
granulomas are well established [2]) using a salmonid
cDNA microarray [43].
Results
Establishment of granulomatous reactions in different 
groups of fish
Gross lesions were observed at the injection sites of all
fish and were characterized by varying degrees of adhe-
sions with tiny fibrous strands between internal organs
such as the pyloric caeca, pancreas and the abdominal
wall. Skewed reactions were observed in fish vaccinated
with M. viscosa vaccines, with mild reactions in FO-7 and
severe ones in FO-8 (with a significant difference of p <
0.01) as demonstrated by the side effects scores (Table 1).
By contrast, only mild reactions with minor differences
were observed between FO-1 and FO-2 (A. salmonicida)
groups. Melaninisation was present in the peritoneal cav-
ities of fish in all groups albeit very mild (results not
shown).
Microscopically, granulomas in the form of well-cir-
cumscribed formations surrounding negative impres-
sions of oil-droplets were observed between the blind
sacs of the pyloric caeca, and between the pylorus and the
pancreas (Figure 1). In mild reactions (FO1, FO-2 and
FO-7) the granulomas were small and localized (Figure
1). The cellular composition consisted of epithelioid cells
with fibroblastic reaction. Lymphocytes, macrophages,
mast cells (eosinophilic granule cells) and a few neutro-
phils were also present (Figure 2). In severe reactions
(FO-8), more granulomas were observed in each reaction
(Figure 3). These reactions had similar cellular composi-
tions as mild reactions but with higher numbers of neu-
trophils, macrophages and lymphocytes (Figure 4) being
present in the granulomas, but with fewer mast cells.
Microarray results
523 genes representing 3.3% of the genes spotted on the
arrays were differentially expressed in all groups, with
very few genes up- or down-regulated in more than one
group (Figure 5). Differentially expressed genes were clas-
sified according to putative functional categories with the
aid of Uniprot and NCBI database searches. The assign-
ment of genes to groups was done preferentially to the
m o s t  s p e c i f i c  g r o u p .  I t  s h o u l d  b e  n o t e d  h o w e v e r  t h a t
most of the assignments were based on gene ontology as
very few functional studies of these genes have been
undertaken in Atlantic salmon.
Groups of differentially expressed genes perceived to be
of particular interest in this study is listed in Additional
file 1. There was a distinct pattern of gene expression in
the head kidneys of fish with severe injection site reac-
Table 1: Side effects and inflammatory scores.
Group Side effect 
score*
Inflammatory score 
(μm2)
FO-1 1.5 (1-2) 50 (30)
FO-2 2 (1-2.5) 590 (340)
FO-7 2 (1-2.5) 490 (240)
FO-8 3 (2-4) 3820 (430)
*Side effects scores of Atlantic salmon following intraperitoneal 
injection with oil adjuvanted vaccines were graded on a scale of 
0-6 and are given as median and range in brackets. Inflammatory 
scores are represented by means and standard errors in brackets. 
n = 15.
Figure 1 Granulomas at injection-site of Atlantic salmon at 12 
weeks following injection. Well-circumscribed granulomas (G) in-
duced by oil-adjuvanted vaccine containing standard amount of Mori-
tella viscosa antigens. Note negative impression of oil droplets (O). Bar 
= 50 μm.Mutoloki et al. BMC Genomics 2010, 11:336
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tions (FO-8) on one side and mild reactions (FO-2 and
FO-7) on the other. These genes can be broadly catego-
rized into innate and adaptive immunity. In the FO-8
group, several genes associated with innate immunity
were up-regulated in the head kidneys including those
encoding humoral defensive proteins such as comple-
ment factors and lysozyme C, the most highly expressed
in this study (7.1 fold). Others were genes associated with
antigen recognition and processing by phagocytes, anti-
gen presentation, cellular signaling including CC
chemokine and leukocyte cell derived chemotaxin 2
(LECT-2), matrix and cellular differentiation, anti-oxida-
tive stress and inflammation. In contrast, very few of
these genes were expressed in FO-7 or FO-2.
As for genes associated with adaptive immunity, clones
of membrane-bound and soluble forms of IgM were up-
regulated in FO-8 while several others associated with T
lymphocytes such as T-cell receptor alpha chain, signal-
Figure 2 Mixed cell infiltrate at injection-site of Atlantic salmon 
at 12 weeks following injection. Cellular composition of inflamma-
tion consisting of macrophages (M), eosinophilic granular cells or mast 
cells (EGC), lymphocytes (L) and a few neutrophils (N). Fibroblasts are 
also distinct (F). Bar = 10 μm.
Figure 3 Severe inflammatory reaction at injection-site of Atlan-
tic salmon at 12 weeks following injection. A severe granulomatous 
reaction with diffuse granulomas (G) induced by vaccine containing 
6× standard M. viscosa antigens (FO-8). O- negative impression of oil 
droplets. Bar = 100 μm.
Figure 4 Cellular composition of severe vaccine granuloma of At-
lantic salmon at 12 weeks following injection. Granulomas consti-
tute of large macrophages (M), several lymphocytes (L), EGCs, and 
multinucleate cells (MGC). Bar = 15 μm.
Figure 5 Regulated genes in different groups of Atlantic salmon 
as determined by microarrays. FO-2 = A. salmonicida (6 × standard 
concentration - sc); FO-7 = M. viscosa (sc); FO-8 = M. viscosa (6 × sc).Mutoloki et al. BMC Genomics 2010, 11:336
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ing lymphocyte activation molecule-associated protein,
Tyrosine kinase ZAP-70 and Thymus-specific serine pro-
tease precursor were down regulated. Only one clone of
IgM heavy chain was up-regulated in FO-7 while none
were observed in FO-2.
As might be expected, a significant number of up-regu-
lated genes were involved in transcription/translation
and metabolism (18.8%). Some unknown genes (16.6%)
were up-regulated, mostly in FO-8 while 22.6% were
down-regulated, mostly in FO-2. 50.9% of the genes could
not be clearly classified into inflammatory and immune
responses (Additional file 2).
Validation of microarray results by real-time qPCR
Twenty-six genes identified by microarrays as differen-
tially regulated were validated by real-time qPCR. Their
selection was based on their putative roles in granuloma-
tous inflammation. A few additional genes were ran-
domly selected and validated by real-time qPCR for
representational purposes. In the FO-8 group, gene
expression results by microarrays were confirmed by
qPCR (88%). Lesser agreement was observed between the
two platforms in FO-7 (54%) and FO-2 (61%) groups.
qPCR results for individual genes like Annexin A1,
C1q-like, lysozyme and C6 were found significantly
higher expressed in FO8 groups compared to the others
(Figure 6). Similarly genes associated with antigen recog-
nition and processing by phagocytes (cathepsin D), anti-
gen presentation (CD209) (Figure 7), cellular signaling
including CC chemokine and leukocyte cell derived
chemotaxin 2 (LECT-2) were similarly upregulated (Fig-
ure 8). Both membrane and secreted forms of IgM were
verifiably up-regulated in FO-8 compared to other groups
(Figure 9). Some T cell related genes such as lymphocyte
cytosolic protein 1 and signaling lymphocyte activation
molecule, though down-regulated in microarrays, were
not differentially expressed (not shown).
Profiling of inflammatory and immune genes
Arginase 1 (p < 0.05), IL-17A (p = 0.007) and IL-17A-
receptor (AR) (p = 0.009) were significantly up-regulated
in FO8 compared to all other groups (Figures 10 and 11).
TGF-β was significantly up-regulated in FO-8 compared
to FO-1 (p = 0.001), with a similar general trend in the
strength of expression in different groups as the severity
of lesions (Figure 11, Table 1). No difference was
observed in the expressions of the genes encoding IFN-γ,
CD4, CD8, IL-6 receptor, IL-10, iNOS, GATA-3 and
Granzyme A between groups (not shown).
Discussion and conclusions
Several genes including complement factors C1q and C6,
mannose binding protein, lysozyme C, C-type lectin
receptor, CD209, Cathepsin D, CD63, LECT-2, CC
chemokine and IgM were identified in the head kidney as
Figure 6 Markers of inflammation expressed in the head kidney 
of Atlantic salmon injected with different oil-based vaccines. 
Quantitative real-time RT-PCR (qPCR) expression of genes identified as 
upregulated by microarray. FO-1 = A. salmonicida (sc); FO-2 = A. salmo-
nicida (6 × sc); FO-7 = M. viscosa (sc); FO-8 = M. viscosa (6 × sc). Gene ex-
pression ratios normalized to Elongation factor 1α (EF1α). Error bars = 
standard error (SE), n= 7. *p < 0.05.
Figure 7 Antigen processing and presentation genes expressed 
in the head kidney of Atlantic salmon injected with different oil-
based vaccines. qPCR expression studies of C-type lectin receptor 
(CLR), antigen recognition and processing by phagocytes (cathepsin 
D) and antigen presentation (CD209) genes identified as upregulated 
by microarray. FO-1 = A. salmonicida (sc); FO-2 = A. salmonicida (6 × sc); 
FO-7 = M. viscosa (sc); FO-8 = M. viscosa (6 × sc). Gene expression ratios 
normalized to EF1α. Error bars = SE, n= 7. *p < 0.05.
Figure 8 Cellular signaling and chemotaxin markers expressed in 
the head kidney of Atlantic salmon injected with different oil-
based vaccines. qPCR expression studies of chemokine (CC) and leu-
kocyte cell derived chemotaxin 2 (LECT 2) genes identified as upregu-
lated by microarray. FO-1 = A. salmonicida (sc); FO-2 = A. salmonicida (6 
× sc); FO-7 = M. viscosa (sc); FO-8 = M. viscosa (6 × sc). Gene expression 
ratios normalized to EF1α. Error bars = SE, n= 7. *p < 0.05.Mutoloki et al. BMC Genomics 2010, 11:336
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associated with severe injection-site granulomatous reac-
tions in this study. The expression of these genes corre-
sponds with gene profiles of an active inflammation [44-
47] and corroborate previous reports that vaccine-based
granulomas are associated with a chronic, active inflam-
mation [2]. Furthermore, the finding that IL-17A and its
receptor (IL-17AR) representing TH17 cells were up-reg-
ulated in fish with severe reactions while none of the
genes directly reflective of TH1 T cell lineage (IFN-γ,
CD4) or TH2 (GATA-3) differentiation were differentially
expressed is interesting in light of the involvement of the
TH17 cells in autoimmune responses [13].
Chronic, active inflammation is consistent with the
presence of neutrophils and macrophages at the injection
site of FO-8. In this group, genes encoding LECT-2 and
CC chemokine were verifiably up-regulated in head kid-
ney indicating an active inflammatory process in the
"draining lymph node." Further to this, the up-regulation
of mRNA transcripts of complement factors C1q and C6,
mannose binding protein, lysozyme C, innate cell-associ-
ated proteins of the C-type lectin receptors, CD209,
Cathepsin D and CD63, anti-oxidative genes such as met-
allothionein and oxidative stress-related genes are addi-
tional indications of active inflammatory processes [48]
in fish with severe granulomatous reactions.
Another intriguing result was the finding that M. vis-
cosa (FO-7&8) is more pro-inflammatory than A. salmo-
nicida (FO-1&2). In natural infection, lethality of these
pathogens is in the reverse [49]. The cause of the differ-
ence in this study is not clear but it is not unlikely that the
structure or quantity of pathogen-associated molecular
patterns (PAMPs) [50], or even the orientation/presenta-
tion of antigens on the surface of oil droplets may be
responsible. The importance of the different factors can
only be solved in future studies.
Macrophages are the main cell type responsible for the
uptake, breakdown, removal or sequestration of antigens.
For an effective response, appropriate activation is neces-
sary. The observed expression of arginase in this study is
consistent with macrophages activated through the alter-
native pathway and is indicative of a TH2 response [51]. In
humans, it has been documented that TH2 cytokines bias
responses towards inadequate activation of macrophages
resulting in less efficient control of Mycobacterium leprae
infections and high bacterial counts inside granulomas
leading to diffuse spreading of the infection [52]. To what
extent macrophage activation plays a role in clearing of
the vaccine antigens in salmonids is not known in detail.
It is not possible to deduce from the results of this study
Figure 9 Immunoglobulin genes expressed in the head kidney of 
Atlantic salmon injected with different oil-based vaccines. qPCR 
expression studies of IgM and immunoglobulin heavy chain constant 
region (IGHC) genes identified as upregulated by microarray. FO-1 = A. 
salmonicida (sc); FO-2 = A. salmonicida (6 × sc); FO-7 = M. viscosa (sc); 
FO-8 = M. viscosa (6 × sc). Gene expression ratios normalized to EF1α. 
Error bars = SE, n= 7. *p < 0.05.
Figure 10 Arginase and IL17AR genes expressed in the head kid-
ney of Atlantic salmon injected with different oil-based vaccines. 
qPCR expression studies of arginase and IL17A receptor (IL17AR) iden-
tified as upregulated by microarray. FO-1 = A. salmonicida (sc); FO-2 = 
A. salmonicida (6 × sc); FO-7 = M. viscosa (sc); FO-8 = M. viscosa (6 × sc). 
Gene expression ratios normalized to EF1α. Error bars = SE, n= 7. *p < 
0.05.
Figure 11 Cytokine genes expressed in the head kidney of Atlan-
tic salmon injected with different oil-based vaccines. qPCR expres-
sion studies of IL17A and transforming growth factor β (TGF-β) genes 
identified as upregulated by microarray. FO-1 = A. salmonicida (sc); FO-
2 = A. salmonicida (6 × sc); FO-7 = M. viscosa (sc); FO-8 = M. viscosa (6 × 
sc). Gene expression ratios normalized to EF1α. Error bars = SE, n= 7. *p 
< 0.05.Mutoloki et al. BMC Genomics 2010, 11:336
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whether the alternative macrophage activation pathway is
an appropriate response but this should be a subject of
further investigation.
The massive up-regulation of IgM mRNA transcripts in
the head kidneys of fish with severe injection-site reac-
tions (Additional file 1) is suggestive of a strong humoral
response, another indication of a TH2 response consistent
with reports of others [53,54]. It must be noted however
that no tests to examine the specificity of antibodies were
conducted in this study. It is thus unknown whether the
bulk of the IgM mRNA transcripts detected in this study
are indications of responses against vaccine-related anti-
gens or if they were directed at self (autoimmune) anti-
gens. Autoimmunity has previously been suggested as
one of the etiologies of vaccine associated side effects in
Atlantic salmon [36].
In fish with mild injection-site reactions, microscopic
examinations revealed a process of wound healing. Mast
cells and macrophages were observed in abundance at the
injection site of fish in these groups (FO-1, FO-2 and FO-
7). These cells have previously been associated with gran-
ulomatous reactions [2,55] and wound healing [42],
although they have also been associated with the initia-
tion of inflammation in Atlantic salmon [56]. In higher
vertebrates TH2 responses have been shown to play an
important role in wound healing [57] with mast cells pro-
ducing or influencing the production of IL-4 and IL-10
tipping the response towards TH2 [58,59]. In the present
study, no significant differences in the expression of
GATA-3 or IL-10 were observed between different
groups. Similarly, no differences were observed for IL-12,
IFN-γ, CD4, CD8 and Granzyme A. As similar antigen
preparations per pair of vaccines were used differing only
in concentrations, the anticipation is that similar TH
responses drove the inflammatory responses in all groups;
the difference in severity being motivated by antigen con-
centration and determined mainly by the innate response.
Interestingly, the expression of IL-17A and its receptor
showed similar trends as the severity of inflammatory
profiles (Figures 10 and 11, and Table 1), being signifi-
cantly up-regulated (p = 0.007 and 0.009, respectively)
only in the group with severe granulomas. IL-17A is a
pro-inflammatory cytokine produced predominantly by
activated T cells. It acts through its receptor IL-17AR
which, although ubiquitously expressed, its main
responses in higher vertebrates are found in epithelial
cells, endothelial cells, fibroblasts, macrophages and den-
d r i t i c  c e l l s  ( r e v i e w e d  i n  r e f .  [ 6 0 , 6 1 ] ) .  I t  i s  a n  e s s e n t i a l
component of the IL-17A signaling whose induction is
required for effective responses [60,62-64]. It has also
been demonstrated to be up-regulated together with IL-
17A in autoimmune diseases [65-67]. IL-17A expression
induces the production of an array of cytokines and met-
alloproteases by fibroblasts, endothelial cells, mac-
rophages and epithelia cells resulting in the induction of
inflammation and recruitment of neutrophils [68]. These
findings suggest that IL-17A/IL-17AR and therefore the
TH17 response contributes to the induction of severe side
effects in line with the higher number of infiltrating neu-
trophils and macrophages in this group. To what extent
autoimmunity as previously reported [36] is involved in
these responses remains elusive as the presence of
autoantibodies was not assessed in this study.
The involvement of TGF-β in severe granulomatous
reaction in this study is compelling given the expression
patterns exhibited in different groups (Figure 11) relative
to the degree of side effect lesions (Table 1). In mammals,
the expression of TGF-β has previously been associated
with the recruitment of polymorphonuclear cells to
inflammatory sites [69]. Together with IL-6, IL-21 or IL-
23, it has also been demonstrated to be essential in the
commitment of naïve T cells into TH17 cells [14,15].
TGF-β is produced by cells of the innate immune system
[70] as well as regulatory T cells (T-regs) [71,72].
Although only the receptor for IL-6 and not the cytokine
itself was examined in the present study and found not to
be induced, it is not unlikely that a different expression
pattern would have been observed with the latter. On the
other hand, this finding may suggest that other cytokines
such as IL-21 or IL-23 act in concert with TGF-β to regu-
late TH17 cells in the induction of severe granulomatous
reactions in Atlantic salmon.
The screening of differentially expressed genes for
granulomatous reactions using microarrays in this study
was done by examining head kidney tissues rather than
the injection site. It is conceivable that more inflamma-
tory genes would be up- or down-regulated at the latter
compared to the former, as most inflammatory genes are
known to act locally. In i.p. vaccinated fish, the injection
site is the abdominal cavity and vaccine components
localize primarily at the pyloric caeca/pancreas area
[2,41]. Because of the anatomical co-localization of the
pylorus with the pancreas, collection of homogeneous
tissue for gene expression studies is problematic. An
alternative approach would be to vaccinate the fish intra-
muscularly and examine gene expression at the injection
site as previously reported [73]. However, for vaccines
routinely administered i.p., this approach would have to
be weighed against the prospect of modifying the
immune response since different routes of vaccination
are known to influence the resulting TH profiles [74].
In conclusion, the profile of the immune responses as
assessed by gene expression to oil-adjuvanted vaccines in
Atlantic salmon is strongly influenced by antigen content
and also the type of antigens included in the vaccine
preparation. There is a variation in the response along anMutoloki et al. BMC Genomics 2010, 11:336
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axis of a chronic, active inflammation on one end to mild
inflammation and wound healing on the other. Gene
expression patterns indicative of neutrophil persistence
and macrophage activation are biased towards a mixed
reaction between TH2 and TH17 profiles in the head
kidney.
Methods
Fish
About 250 Atlantic salmon (Salmo salar L; Bolax strain)
weighing approximately 42 g each were procured from
Lindås Fiskeoppdrett AS, Vågseidet in Norway. The fish
were reared in continuously running fresh water tanks at
Stiftelsen Industrilaboratoriet Høyteknologisenteret
(ILAB) in Bergen, Norway. The water temperature was
17°C on average and the fish were fed on commercial dry
pellets (EWOS Innovation, Bergen, Norway).
Vaccines
Injection preparations used in this study are shown in
Table 2. All preparations were bivalent experimental vac-
cines (with equal concentrations of infectious pancreatic
necrosis virus in all vaccines as second antigens) from
PHARMAQ AS, Overhalla, Norway, produced according
to in-house standard procedures. The oil-based antigen
preparations were formulated as water-in-oil (w/o),
where the water phase (containing bacterial antigens) was
dispersed into an oil phase (continuous phase containing
emulsifiers and stabilizers). Emulsification of the antigens
with adjuvant was done using a homogenizer with a stan-
dard emulsification stator/rotor connected to an emulsior
screen. The potency of the standard vaccines was accord-
ing to specifications given in European Pharmacopoeia
monographs for Aeromonas salmonicida, RPS > 80 and
for Moritella viscosa the potency was RPS > 60 and 60%
control mortality in the non-vaccinated (according to
internal standards of PHARMAQ). Sterility, free formal-
dehyde, inactivation, stress, viscosity and droplet size
tests were all performed and standardized on blended
bacterin according to standard procedures in the labora-
tory.
Randomisation, marking and vaccination of the fish
The selection of fish was done by dip-netting followed by
sequential allocation into groups. Four groups compris-
ing 50 fish each were included in the present experiment.
Marking was done by fin clipping. Prior to marking, the
fish were anaesthetised using Chlorobutanol (Sigma,
Steinheim, Germany) dissolved in rearing water at a con-
centration of 0.5 ml/L. The fish were vaccinated by inject-
ing 0.1 ml of vaccine intraperitoneally (i.p.) through the
ventral midline, about 1 to 1.5 pelvic fin lengths anterior
to the pelvic fin base. Self-refilling syringes (Socorex,
Ecublens, Switzerland) with 0.6 × 3 mm needles
(Unimed, Lausanne, Switzerland) were used. After
immunization, all the fish were placed into two fiberglass
tanks, each with a water capacity of 500 L. Post vaccina-
tion mortality and appetite of the fish were monitored
daily.
Sample collection and processing
Sampling was done at 12 weeks post vaccination (p.v.).
Fifteen fish from each group were randomly selected by
dip netting, anaesthetized and then sorted into groups.
Sampling was done as previously described [2]. Briefly,
the fish were stunned by a blow to the head and the gill
vein severed. A sample (max volume = 10 × 10 × 5 mm) of
pyloric caeca and surrounding tissues (designated as the
injection site) and head kidney were collected from each
fish and stored in 10% phosphate buffered formalin for a
minimum of 4 days. Thereafter, the samples were pro-
cessed according to standard procedures employed for
hematoxylin and eosin (H&E) staining. In addition, paral-
lel samples of the head kidney and pyloric caeca were col-
lected from individual fish and stored separately in
RNAlater® (QIAGEN, Hilden, Germany) according to the
manufacturer's instructions until required.
Assessment of gross and microscopic lesions
Gross lesions in the peritoneal cavity of the fish were
graded on an arbitrary scale of 0-6, where 0 = no lesions
and 6 = severe as previously described [75]. For micro-
scopic lesions, the size of inflammatory reaction of each
fish was assessed by calculating the area of the inflamed
lesions using computer-assisted microscopy on H&E
stained sections as previously described [41]. Briefly,
well-calibrated microscopical images were acquired at
100 × magnification by using a computer-controlled digi-
tal camera mounted on a light microscope. The circum-
ferences of inflamed areas in digital images were marked
Table 2: Vaccine preparations used in the present study.
Antigens
Vaccine* Aeromonas 
salmonicida
Moritella viscosa
FO-1 Standard 
concentration
0
FO-2 6 × standard 
concentration
0
FO-7 0 Standard 
concentration
FO-8 0 6 × standard 
concentration
*All vaccines were adjuvanted with mineral oil and were 
formulated as water-in-oil emulsions.Mutoloki et al. BMC Genomics 2010, 11:336
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manually. The number of pixels within the marked region
was then converted to area with the help of the Image-
Pro® Analysis program (Media Cybernetics, L.P., Silver
Spring, USA).
Data on gross lesions was subjected to Fisher's exact
test while inflammatory reactions between groups were
analysed by linear regression as previously described [42].
Microarray-based screening of gene transcripts in head 
kidney tissues
Head kidney tissues, rather than those of the injection
site (pylorus/pancreas) were used for the screening of
gene transcripts by microarrays in this study due to the
difficulty in obtaining homogeneity in the samples of the
latter as the organs (pyloric caeca and pancreas) are ana-
tomically intertwined. Because of this it was perceived
that using injection site tissues would not give represen-
tative gene expression results.
RNA isolation
RNA from head kidney tissues stored in RNAlater was
isolated by using the RNeasy® minikit (QIAGEN, Hilden,
Germany). Each tissue was homogenized by subjecting it
to a mixer mill MM301 (Retsch GmbH & Co., Haan, Ger-
many) for 2 min at 20 Hz in buffer RLT followed by total
RNA extraction with on-column DNAse treatment
according to the manufacturer's protocol to minimize
DNA contamination. The quantification of RNA, purity
and integrity assessment were done by using a NanoDrop
ND-1000 spectrophotometer (NanoDrop technologies,
Inc., Wilmington, USA) and the Agilent 2100 Bioanalyzer
(Agilent technologies).
Microarray study design and target preparation
Fish were grouped according to the vaccines adminis-
tered (Table 2). The group with the least gross and
inflammatory changes (FO-1) was used as the reference
in microarray experiments. Out of 15 fish sampled in
each group, only total RNA from 12 fish, chosen on the
basis of abundance and quality/integrity, was used for
downstream analysis (Figure 12).
RNA amplification
I n  o r d e r  t o  g e n e r a t e  s u f f i c i e n t  a m o u n t s  o f  t a r g e t s  f o r
hybridization, each total RNA pool was subjected to one
round of amplification using the Amino Ally Mes-
sageAMP™ II aRNA amplification kit (Ambion, Austin,
USA) starting with 2 μg. Briefly, reverse transcription
(RT) to synthesize the first cDNA strand was done using
oligo(dT) primers containing a T7 promoter sequence.
The RNA and primer mix was first denatured at 70°C for
10 min prior to the addition of the RT master mix. The
first strand synthesis reaction was incubated at 42°C for 2
hrs. The second cDNA strand was synthesized by the
addition of the second strand master mix and incubated
at 16°C for 2 hrs. The resulting double stranded cDNA
was purified by using column-based reagents, according
to the protocol supplied with the kit. Finally, amino allyl-
modified anti-sense RNA (aRNA) was synthesized by the
addition of an in-vitro transcription master mix contain-
ing a 1:1 ratio of UTP to amino allyl-modified UTP and
held at a temperature of 37°C for 14 hrs. The aRNA was
then purified and stored at -80°C until required.
Coupling of aRNA was done with either Cy3 or Cy5 dye
according to the Amino Ally MessageAMP™ II aRNA
Amplification Kit protocol with minor modifications.
Briefly, one vial of Cy3 or Cy5 monofunctional reactive
dyes (Amersham, Buckinghamshire, UK) was resus-
pended in 22 μl of DMSO prior to coupling. 3 μg of aRNA
was dried to completion in a vacuum centrifuge (Savant
Instruments, Inc., Farmingdale, NY). The aRNA was
resuspended in 4.5 μl of coupling buffer. Thereafter, 5.5 μl
of dye was added to the aRNA:coupling buffer and incu-
bated for 30 min in the dark. 2.25 μl of 4 M hydroxylala-
mine was then added to quench the reaction followed by
12.75 μl of water to obtain a total volume to 30 μl. Dye
labeled aRNA purification was done according to the
manufacturer's instructions.
Array hybridization, scanning and analysis
The fabrication of the salmonid microarrays used in the
present study is described elsewhere [43]. A complete
description and list of the probes used on the arrays is
available at http://web.uvic.ca/grasp.
T h e  e x p e r i m e n t s  w e r e  d e s i g n e d  t o  c o m p l y  w i t h
MIAME guidelines [76]. Three biological and 2 techni-
cal replicates (dye-swapped) were utilized in different
combinations to hybridize to 18 arrays (Figure 12). The
assignment of microarrays to treatment groups for
hybridization was done randomly by using a random
number generator. To minimize technical variability,
target synthesis and hybridizations were done in
Figure 12 Microarray study design. Total RNA from 12 fish in each 
group was subdivided into pools of 4 fish each and subsequently used 
for hybridization. Vaccine A represents the reference group (FO-1 A. 
salmonicida standard concentration).Mutoloki et al. BMC Genomics 2010, 11:336
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batches of 6 where all treatment groups were equally
represented.
Post-print processing of arrays was done by washing
2 × 5 min in 0.2% SDS, 5 × 1 min in MilliQ water fol-
lowed by immersion in MilliQ water at 100°C for 3
min. The slides were dried by centrifugation at 512 × g
for 5 min.
Array were prehybridized by placing them in (5 ×
SSC, 1% SDS and 3% BSA (Sigma, Steinheim, Ger-
many)) and incubating at 49°C in a water bath for 11/2
hrs. Thereafter , the arrays were washed thrice for 20
sec in MilliQ water and dried by centrifugation as
above. For hybridization, 500 ng of labeled target
reconstituted to a final volume of 26 μl, 30 μL of 2 ×
formamide hybridization buffer (Genisphere, Hart-
field, USA) and 4 μl LNT dT blocker were used.
Hybridization was done at 49°C in a water bath for 16
hrs. The arrays were washed first in 2 × SSC, 0.1% SDS
for 10 min at 49°C, 2 × 5 min in 2 × SSC, 0.1% SDS at
room temperature, 2 × 5 min in 1 × SSC, 4 × 5 min in
0.1 × SSC followed immediately by centrifugation at
512 × g for 5 min.
Imaging was done at 10 μm resolution using ScanAr-
ray™ Express microarray scanner (Packard Bioscience).
The Cy3 and Cy5 cyanine fluors were excited at 543
nm and 633 nm, respectively, at the same laser power
(90%), with adjusted photomultiplier tube settings
between slides to balance the Cy3 and Cy5 channels.
Image analysis and fluorescent intensity data was
extracted from Tiff images using ImaGene™ 5.6 Stan-
dard Edition software.
Data analysis (correction of background, setting of
background corrected values < 0.01 to 0.01), normal-
ization (Lowess) and analysis (formation and manipu-
lation of fold change transcript lists) were performed
in GeneSpring Gx (Agilent T echnology). Clones were
assigned as either up or down regulated based on two
conditions: a ratio of at least 1.5 fold change in at least
3 of the six replicates and also a statistical p value of <
0.05. The data is deposited at NCBI's GEO repository
under accession number GSE8826  and Platform
GPL2716.
Validation of microarray results by quantitative RT-PCR
The results obtained by microarray experiments were
verified by real-time quantitative PCR (qPCR) by using
the LightCycler 2.0 instrument and LightCycler® FastStart
DNA MasterPLUS  SYBR Green I (Roche Diagnostics
GmbH, Manheim, Germany) as previously described
[77].
One microgram of total RNA from the head kidney or
pyloric caeca of individual subjects was reverse tran-
scribed using oligo (dT)20 and Superscript III Reverse
transcriptase (Invitrogen, Carlsbad, CA, USA) according
to the manufacturer's instructions. Thereafter, cDNA was
scaled up to 100 μl with water. Two microlitres of the
diluted cDNA was used as template for each qPCR reac-
tion.
The primers employed in the quantification of PCR
reactions are presented in Table 3. Designing of the prim-
ers was done using Primer3 software (Whitehead Insti-
tute of Biomedical Research, MA., USA) while primers
were procured from MWG Biotech AG, Germany. The
generation of a single product of the expected size for
each assay was confirmed by electrophoresis of the PCR
(ordinary) and also LightCycler q-PCR product on a 2%
agarose gel. Quantitative PCR was done in duplicate and
the melting curve analysis was applied to confirm the for-
mation of a single product.
Data analysis was done by using the LightCycler soft-
ware version 4.0. The second-derivative maximum cal-
culation was used to determine the crossing point
(Cp). Since the focus was relative expression, the cali-
brator-normalized relative gene expression (Elonga-
tion factor 1α as the reference gene) without efficiency
correction was employed for analysis. For statistical
purposes, relative gene expression ratios were normal-
ized by log transformation. Linear regression analysis
was then performed with the help of STATA™ SE 9 for
windows (Stata Corp. College station, TX, USA). The
gene expression ratios were taken as response variables
while the vaccination groups were defined as dummy
variables.
To further characterize the immunological responses
driving granuloma formation, the expression of addi-
tional genes not found on the microarrays including IFN-
γ, IL-6 receptor, IL-10, TGF-β, IL-17A, IL-17A-receptor
(IL17-AR), CD4, CD8 and iNOS was done as already
described above. For arginase 1, an MGB probe (Applied
Biosystems, Warrington, UK) and primers designed to
anneal at the splice site were used in combination with
the LightCycler® Taqman® Master reagents on the Light-
Cycler instrument. A two-step PCR program (95°C for 10
sec; 60°C for 1 min) was utilized. For GATA-3, a Taqman
probe in combination with LightCycler reagents as
described above was used. All primer sequences are pre-
sented in Table 3.
Additional material
Additional file 1 Gene expression profiles by vaccine groups. Presents 
a comparison of gene expression profiles between different groups of fish, 
categorized according to putative gene function.
Additional file 2 Non-immune gene differentially regulated. Presents 
genes that were up or down regulated on microarrays but were classified as 
not linked to inflammatory or immune responses in the different vaccine 
groups.Mutoloki et al. BMC Genomics 2010, 11:336
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Table 3: Primers used for real-time quantitative PCR.
Accession no. Name Direction Sequence T*A P** size (bp)
CB510337 T cell receptor alpha chain (TCAC) Fwd GCCTGGCTACAGATTTCAGC 66 107
Rev GGCAACCTGGCTGTAGTAGC
CA052383 Complement component C6 Fwd TCCAACGTGCCACTCTCCTC 64 131
Rev CCGAACAGGGCTTCTACACC
CA044561 L-plastin (Lymphocyte cytosolic protein 1) Fwd CATGCGAACACAGTCAGAACC 62 111
Rev CAACGCCAAGTACGCTATCAC
CA059313 Annexin A5 Fwd GAAACTTCAACGCCAACCAAG 60 115
Rev TGTCTCTGGCTGTTGCTACG
CA062753 SH2 domain protein 1A Fwd GGGAGTAGTCTCTGCTGTCC 62 95
Rev GGCTCTACTGCCTCTGTGTG
CB493440 Proteasome subunit alpha type 4 Fwd GTTCTAACCAATGAGCTGAGG 60 89
Rev AACGCTGTCACCAACTGCTC
CB511680 Lysozyme C Fwd CACCGACTATGGCATCTTCC 58 129
Rev CTGACCGCCACTGTGATGTC
CA767935 Cathepsin D Fwd CAGGCTGGTAAGACCATCTGC 58 127
Rev TGTTGTCACGGTCGAACACAG
DN048269 Complement C3a Fwd GAGGAAAGGTGAGCCAGATG 58 106
Rev TGTGTGTGTCGTCAGCTTCG
CA043655 Interferon regulatory factor-1 (IRF-1) Fwd GATGGGACCTGAACAAGGATG 58 132
Rev GAAGGGAGTTCATTGCACAGC
A064221 MHC-II alpha Fwd GAACACAGCAGGACCCACAC 58 134
Rev TCTCCAGTCTGCCCTTCACC
CX984314 Leukocyte cell derived chemotaxin (LECT-2) Fwd GCGAGATGGTCAAGTTTGGTC 58 115
Rev TGATGCTCACGGTTTCCTCTG
CK991004 Immunoglobulin heavy chain constant region (IGHC) Fwd AGATGGACGCTTGTGGATCTC 58 118
Rev GGTCTGGAGCAATGGGACAG
CB488287 Secreted protein acidic and rich in cysteine precursor 
(SPARC)
Fwd CCAGCAGGTCCAGGGAGTG 60 156
Rev TGCGTATGAGGGACTGGCTG
CA055453 Glutathione peroxidase Fwd GCAATCAGTTCGGACATCAGG 60 131
Rev GTCCTTCCCATTCACATCCAC
CA050443 C1q-like adipose specific protein Fwd GTGATGACATTTTTGAAGATCAGG 60 104Mutoloki et al. BMC Genomics 2010, 11:336
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Rev AATAAGGAGAGAATGAAGGTGATC
CB516930 CD209 antigen Fwd CCCATCTCCAATCCCCTTCC 60 119
Rev CCTGCACAGCAAGGAACAGC
CA051187 Mannose-binding protein C precursor Fwd CAAGAGGGGCTTGGTGTTGG 60 107
Rev TGTTGTCAACATTGAGCCATGC
CA039888 IgM heavy chain membrane bound form Fwd TCTGGGTTGCATTGCCACTG 60 121
Rev GTAGCTTCCACTGGTTTGGAC
CB492684 Annexin A1 Fwd AGGAAGGGAACAGACTGCTC 60 120
Rev AATAGCCTTTGCCACATCCAC
CB503743 CC chemokine (CCL 19) Fwd CCATGTAGCAGCAAGCACAG 66 128
Rev GGCAGCTATCCGACATCCTC
CB510333 Cd 63 Fwd AACAGTCTGACACCCCATCTG 58 97
Rev TGTGCCAGACTCCTGCTGTG
CA056108 C type Lectin receptor A (CTL) Fwd ATCCTGCACAGCAAGGAACAG 58 128
Rev TTGTCCACCCATCTCCAATCC
CK990996 Metallothionine Fwd GGACAGCAGGGGCAGCAAC 58 128
Rev GCGATCAAAAACTGGAACATGG
CA058146 Putative complement factor D Fwd GAATCCATCGGCTGTACGAAG 64 115
Rev CCGTTGGTGTGTAATGGGATG
AY693393 CD8α Fwd CACTGAGAGAGACGGAAGACG 56 174
Rev TTCAAAAACCTGCCATAAAGC
DQ867018 CD4 Fwd GAGTACACCTGCGCTGTGGAAT 58 123
Rev GGTTGACCTCCTGACCTACAAAGG
FJ263446 Interferon gamma (IFN-γ) Fwd CTAAAGAAGGACAACCGCAG 60 159
Rev CACCGTTAGAGGGAGAAATG
AF088999 Inducible nitric oxide sythase (iNOS) Fwd GGAGAGCCTTCTGGTTG 60 116
Rev ACCTTAACTTGTTCCTGAGATAC
EF165028 IL-10 Fwd CGCTATGGACAGCATCCT 59 84
Rev AAGTGGTTGTTCTGCGTT
BK001401 Arginase 1b Fwd CATTGGCTTGAGAGACGTGGAT 60 68
Rev AGTAACCTTTGACACCCAGCAA
Arginase 1b (Probe) 6FAM-CAGAAGAGCACCATATCC
AF321836 Elongation factor-1 Fwd GCTGTGCGTGACATGAGG 60 88
Table 3: Primers used for real-time quantitative PCR. (Continued)Mutoloki et al. BMC Genomics 2010, 11:336
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